Eblasakimab

Cat. No. M40609

All AbMole products are for research use only, cannot be used for human consumption.

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation

Purity: >99.0%
COA
MSDS

Product Information

Biological Activity

Eblasakimab is a potential first-in-class, novel monoclonal antibody that targets the IL-13 receptor alpha 1 subunit (IL-13Rα1) and inhibits signaling of the pro-inflammatory cytokines IL-4 and IL-13. It can be used in studies related to atopic dermatitis (AD).

Chemical Information

CAS Number	2445460-16-0
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

References

[1] Karen A Veverka et al. J Am Acad Dermatol. Safety and efficacy of eblasakimab, an IL-13Rα1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study

[2] Ferda Cevikbas et al. Clin Immunol. Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteers

[3] Yuliya Lytvyn et al. Pharmaceutics. Targeting Interleukin 13 for the Treatment of Atopic Dermatitis

Related IL Receptor/Related Products
IL-15-IN-1 IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.
IL-17 modulator 3 IL-17 modulator 3 is an IL-17 modulator.
IL-17 modulator 4 IL-17 modulator 4 is a proagent of IL-17 modulator 1.
IL-17A modulator-3 IL-17A modulator-3 is a IL-17A modulator.
IL-17 modulator 4 sulfate IL-17 modulator 4 sulfate is a proagent of IL-17 modulator 1.

Catalog

By Signaling Pathways

By Product Type

Signaling Pathways

Eblasakimab

Price and Availability

Quality Control & Documentation

Biological Activity

Chemical Information

References

Get to Know Us

Customer Support

Resources

Contact Us